![Vickie Reed](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Vickie Reed
Director/Miembro de la Junta en EVOKE PHARMA, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Vickie Reed
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EVOKE PHARMA, INC. | Director/Miembro de la Junta | 13/05/2021 | - |
Independent Dir/Board Member | 13/05/2021 | - | |
DMK PHARMACEUTICALS CORPORATION | Director/Miembro de la Junta | 24/05/2022 | - |
Independent Dir/Board Member | 24/05/2022 | - |
Historial de carrera de Vickie Reed
Antiguos cargos conocidos de Vickie Reed.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MIRATI THERAPEUTICS | Comptroller/Controller/Auditor | 06/01/2020 | 16/05/2022 |
Director Financiero/CFO | 01/11/2021 | 16/05/2022 | |
Corporate Officer/Principal | 01/12/2016 | 06/01/2020 | |
ZOGENIX, INC. | Comptroller/Controller/Auditor | - | 01/01/2022 |
Director Financiero/CFO | - | 01/01/2022 | |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formación de Vickie Reed.
The University of Colorado | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
EVOKE PHARMA, INC. | Health Technology |
DMK PHARMACEUTICALS CORPORATION | Health Technology |
Empresas privadas | 3 |
---|---|
Mirati Therapeutics, Inc.
![]() Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Zogenix, Inc.
![]() Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
![]() Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Vickie Reed
- Experiencia